We are live on
!
Find out more
ANI Pharmaceuticals
ANIP
ANIP
163 hedge funds and large institutions have $422M invested in ANI Pharmaceuticals in 2017 Q4 according to their latest regulatory filings, with 30 funds opening new positions, 46 increasing their positions, 54 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
131% more first-time investments, than exits
New positions opened: 30 | Existing positions closed: 13
25% more capital invested
Capital invested by funds: $337M → $422M (+$85.3M)
12% more funds holding
Funds holding: 146 → 163 (+17)
1.12% more ownership
Funds ownership: 55.1% → 56.22% (+1.1%)
15% less repeat investments, than reductions
Existing positions increased: 46 | Existing positions reduced: 54
82% less call options, than puts
Call options by funds: $4.01M | Put options by funds: $22.4M
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
163
Holders Change
+17
Holders Change %
+11.64%
% of All Funds
3.7%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
30
Increased
46
Reduced
54
Closed
13
Calls
$4.01M
Puts
$22.4M
Net Calls
-$18.4M
Net Calls Change
-$6.09M
Top Buyers
| 1 |
Invesco
Atlanta,
Georgia
|
+$16.7M |
| 2 |
CAM
Cortina Asset Management
Milwaukee,
Wisconsin
|
+$5.88M |
| 3 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$3.01M |
| 4 |
MWNA
Marshall Wace North America
New York
|
+$2.92M |
| 5 |
Nomura Holdings
Tokyo,
Japan
|
+$2.72M |
Top Sellers
| 1 |
First Manhattan
New York
|
-$14.2M |
| 2 |
WAM
Weiss Asset Management
Boston,
Massachusetts
|
-$8.92M |
| 3 |
FIM
Foresters Investment Management
New York
|
-$4.88M |
| 4 |
Renaissance Technologies
New York
|
-$3.55M |
| 5 |
JP Morgan Chase
New York
|
-$3.2M |
